These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18015442)

  • 21. [Treatment of syphilis with massive doses of mapharsen and bismuth].
    KRAUS Z; SABATOVA M
    Cesk Dermatol; 1950 Oct; 25(Suppl):67-73. PubMed ID: 14783783
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mapharsen treatment of syphilis].
    AKOVBIAN AA; FILATOVA AA
    Vestn Venerol Dermatol; 1948; 29(1):29-33. PubMed ID: 18887741
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of acute syphilitic orchitis and generalized syphilis of rabbits with repository penicillin products alone and in combination with mapharsen and bismuth salicylate.
    KOLMER JA
    Am J Syph Gonorrhea Vener Dis; 1950 Jan; 34(1):45-56. PubMed ID: 15398704
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contribution to the study of the therapeutic action of mapharsen in syphilis].
    TRIMIGLIOZZI G
    G Ital Dermatol; 1947; 88(2):152-80. PubMed ID: 20255359
    [No Abstract]   [Full Text] [Related]  

  • 25. Penicillin in the treatment of experimental syphilis of rabbits. VII. Penicillin "S-R" and procaine penicillin G in peanut oil with aluminum monostearate, alone and in combination with oxophenarsine hydrochloride (mapharsen) or bismuth subsalicylate.
    KOLMER JA
    AMA Arch Derm Syphilol; 1951 Aug; 64(2):169-76. PubMed ID: 14856407
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of treatment of contagious forms of syphilis using the American preparation mapharsen].
    MEMORSKY VP; ZERNOVA MG
    Vestn Venerol Dermatol; 1945; (2):18-23. PubMed ID: 20280566
    [No Abstract]   [Full Text] [Related]  

  • 27. The synergistic action of penicillin and mapharsen (oxophenarsine hydrochloride) in the treatment of experimental syphilis.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Vener Dis Inf; 1946 Jan; 27():3-9. PubMed ID: 21009441
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience with mapharsen].
    LAUSECKER H
    Wien Klin Wochenschr; 1950 Jun; 62(25):448-50. PubMed ID: 15443508
    [No Abstract]   [Full Text] [Related]  

  • 29. METHIONINE PROTECTS AGAINST MAPHARSEN LIVER INJURY IN PROTEIN-DEPLETED DOGS.
    Goodell JP; Hanson PC; Hawkins WB
    J Exp Med; 1944 Jun; 79(6):625-32. PubMed ID: 19871391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reiter's syndrome; a report of two cases with response in one to large doses of mapharsen.
    KHOURY EN
    J Urol; 1947 Oct; 58(4):269-71. PubMed ID: 20266241
    [No Abstract]   [Full Text] [Related]  

  • 31. [The action of mapharsen on serum reactions to the lue].
    MARCHI C
    Rass Med Sarda; 1948; 50 Suppl.(3-4):27-33. PubMed ID: 18105196
    [No Abstract]   [Full Text] [Related]  

  • 32. [The neo-arsenic antisyphilitic mapharsen and standard methods of use].
    SASA K
    Nihon Ishikai Zasshi; 1948 Jun; 22(5):166-8. PubMed ID: 18884917
    [No Abstract]   [Full Text] [Related]  

  • 33. Reactions to twenty-day intensive therapy with mapharsen and bismuth for syphilis with a note on the use of BAL in their management.
    CORMIA FE; BLAUNER SG
    Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):135-49. PubMed ID: 20289293
    [No Abstract]   [Full Text] [Related]  

  • 34. Mapharsen: Its Use in the Treatment of Syphilis.
    Miller HE; Epstein NN; Simpson RG
    Cal West Med; 1936 Oct; 45(4):321-4. PubMed ID: 18743825
    [No Abstract]   [Full Text] [Related]  

  • 35. The Use of Mapharsen in the Treatment of Syphilis.
    Peterson SC
    Can Med Assoc J; 1937 Feb; 36(2):172-3. PubMed ID: 20320530
    [No Abstract]   [Full Text] [Related]  

  • 36. THE VALUE OF MAPHARSEN IN THE TREATMENT OF CONGENITAL SYPHILIS.
    Morgan EA
    Can Med Assoc J; 1938 Jan; 38(1):53-5. PubMed ID: 20320834
    [No Abstract]   [Full Text] [Related]  

  • 37. Mapharsen in Treatment of Syphilis.
    Br Med J; 1936 Feb; 1(3918):269-70. PubMed ID: 20779722
    [No Abstract]   [Full Text] [Related]  

  • 38. Arthur Tatum, Parke-Davis, and the discovery of Mapharsen as an antisyphilitic agent.
    Swann JP
    J Hist Med Allied Sci; 1985 Apr; 40(2):167-87. PubMed ID: 3891839
    [No Abstract]   [Full Text] [Related]  

  • 39. [Jaundice resulting from mapharsen-bismuth and mapharsen-mercury treatment].
    SHAPOSHNIKOV OK
    Vestn Venerol Dermatol; 1948; 29(1):55. PubMed ID: 18887751
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the influences of mapharsen on fixed neoarsphenamine eruptions; preliminary report.
    ABE M
    Tohoku J Exp Med; 1950 May; 52(1-2):48. PubMed ID: 14776730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.